|
1
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jane EP, Premkumar DR, Morales A, Foster
KA and Pollack IF: Inhibition of phosphatidylinositol 3-kinase/AKT
signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a
caspase-dependent manner through mitochondrial dysfunction and DNA
damage response in established and primary cultured glioblastoma
cells. J Pharmacol Exp Ther. 349:1–60. 2014.
|
|
4
|
Castellino RC and Durden DL: Mechanisms of
disease: the P13K-Akt-PTEN signaling node - an intercept point for
the control of angiogenesis in brain tumors. Nat Clin Pract Neurol.
3:682–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roell D, Rösler TW, Degen S, Matusch R and
Baniahmad A: Antiandrogenic activity of anthranilic acid ester
derivatives as novel lead structures to inhibit prostate cancer
cell proliferation. Chem Biol Drug Des. 77:450–459. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smirnova ZS, Ermakova KV, Kubasova IY,
Borisova LM, Kiselyova MP, Oborotova NA, Meerovich GA and
Luk’yanets EA: Experimental study of combined therapy for malignant
glioma. Bull Exp Biol Med. 156:480–482. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagane M: Anti-angiogenic therapy for
malignant glioma. Gan To Kagaku Ryoho. 41:141–147. 2014.(In
Japanese).
|
|
8
|
Taraphdar AK, Madhumita R and Bhattacharya
RK: Natural products as inducers of apoptosis: Implication for
cancer therapy and prevention. Curr Sci. 80:1387–1396. 2001.
|
|
9
|
Petrangeli E, Lenti L, Buchetti B, et al:
Lipido-sterolic extract of Serenoa repens (LSESr, Permixon)
treatment affects human prostate cancer cell membrane organization.
J Cell Physiol. 219:69–76. 2009.
|
|
10
|
Chua T, Eise NT, Simpson JS and Ventura S:
Pharmacological characterization and chemical fractionation of a
liposterolic extract of saw palmetto (Serenoa repens):
effects on rat prostate contractility. J Ethnopharmacol.
152:283–291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Penugonda K and Lindshield BL: Fatty acid
and phytosterol content of commercial saw palmetto supplements.
Nutrients. 5:3617–3633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Y, Ikezoe T, Zheng Z, Taguchi H,
Koeffler HP and Zhu WG: Saw palmetto induces growth arrest and
apoptosis of androgen-dependent prostate cancer LNCaP cells via
inactivation of STAT 3 and androgen receptor signaling. Int J
Oncol. 31:593–600. 2007.PubMed/NCBI
|
|
13
|
Ding D, Wei S, Song Y, Li L, Du G, Zhan H
and Cao Y: Osthole exhibits anti-cancer property in rat glioma
cells through inhibiting PI3K/Akt and MAPK signaling pathways. Cell
Physiol Biochem. 32:1751–1760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vitucci M, Karpinich NO, Bash RE, et al:
Cooperativity between MAPK and PI3K signaling activation is
required for glioblastoma pathogenesis. Neuro Oncol. 15:1317–1329.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei Y, Jiang Y, Zou F, et al: Activation
of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic
capacity of glioma stem cells. Proc Natl Acad Sci USA.
110:6829–6834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barnholtz-Sloan JS, Sloan AE and Schwartz
AG: Relative survival rates and patterns of diagnosis analyzed by
time period for individuals with primary malignant brain tumor,
1973–1997. J Neurosurg. 99:458–466. 2003.PubMed/NCBI
|
|
17
|
Silvestri I, Cattarino S, Aglianò A, et
al: Effect of Serenoa repens (Permixon(R)) on the expression
of inflammation-related genes: analysis in primary cell cultures of
human prostate carcinoma. J Inflamm (Lond). 10:112013.
|
|
18
|
Akl H, Vervloessem T, Kiviluoto S,
Bittremieux M, Parys JB, De Smedt H and Bultynck G: A dual role for
the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus
endoplasmic reticulum. Biochim Biophys Acta. 14:S0167–S4889.
2014.PubMed/NCBI
|
|
19
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis a basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Los M, Burek CJ, Stroh C, et al:
Anticancer drugs of tomorrow: apoptotic pathways as targets for
drug design. Drug Discov Today. 8:67–77. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu Q, Li Y, Mu K, Li Z, Meng Q, Wu X, Wang
Y and Li L: Amplification of Mdmx and overexpression of MDM2
contribute to mammary carcinogenesis by substituting for p53
mutations. Diagn Pathol. 9:1–8. 2014.PubMed/NCBI
|
|
22
|
Han L, Zhang AL, Xu P, et al: Combination
gene therapy with PTEN and EGFR siRNA suppresses U251 malignant
glioma cell growth in vitro and in vivo. Med Oncol. 27:843–852.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Choi JW, Schroeder MA, Sarkaria JN and
Bram RJ: Cyclophilin B supports Myc and mutant p53-dependent
survival of glioblastoma multiforme cells. Cancer Res. 74:484–496.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gonzalez J and de Groot J: Combination
therapy for malignant glioma based on PTEN status. Expert Rev
Anticancer Ther. 8:1767–1779. 2008. View Article : Google Scholar : PubMed/NCBI
|
